July 5, 2010 - Study Finds Drug Prices In Europe Comparable To Those In US.

The Financial Times (7/5, Jack) reported on a study from the London School of Economics to be published in Health Economics, Policy and Law. The study shows that despite claims by US pharmaceutical manufacturers, the prices for patented medicines in the US are comparable to those in other OECD nations. The Times considered the report particularly damaging to arguments made by PhRMA, which has long claimed that European policies, such as regulation and price controls, make the continent less appealing to researchers. The new data suggest that drug maker profits, and prices, in the US are only marginally higher than in Europe.